Hazard Hub

Product quality Recalls in Canada — Page 6

340 recalls involving product quality — most are health products recalls. Newest first, updated daily from government open data.

Showing 151–180 of 340

Health Products Type II
2024-09-27

Mint-Risperidon tablet: Out of specification (Impurity)

Product quality

View recall details →

Health Products Type II
2024-09-25

Cromolyn eye drops: Out of specification (Antimicrobial efficacy)

Product quality

View recall details →

Health Products Type II
2024-09-16

Refresh Lacri-Lube Ophthalmic ointment: Sterility concerns

Product quality

View recall details →

Health Products Type I
2024-09-13

Panhematin powder for solution: Sterility concern

Product quality

View recall details →

Health Products Type II
2024-09-11

Jamp Telmisartan-HCT tablet; Out-of-Specification (Assay)

Product quality

View recall details →

Health Products Type II
2024-09-11

AG Telmisartan-HCT Tablet: Out of specification (Assay)

Product quality

View recall details →

Health Products Type II
2024-09-09

Vitamin D3: Overweight & Underweight tablets

Product quality

View recall details →

Health Products Type II
2024-09-09

Jamp-Acetaminophen tablet: Overweight & Underweight tablets

Product quality

View recall details →

Health Products Type II
2024-09-09

Jamp-Telmisartan tablet: Overweight & Underweight tablets

Product quality

View recall details →

Health Products Type II
2024-09-09

AG-Telmisartan tablet: Overweight & Underweight tablets

Product quality

View recall details →

Health Products Type I
2024-09-06

JAMP-Clopidogrel : may contain overweight or underweight tablets

Product quality

View recall details →

Health Products Type I
2024-09-06

AG-Clopidogrel : may contain overweight or underweight tablets

Product quality

View recall details →

Health Products Type II
2024-09-06

JAMP-Pyridostigmine Bromide; Overweight & Underweight tablets

Product quality

View recall details →

Health Products Type II
2024-09-06

MJ Tonic Nigelle nasal; Out of specification (Peroxide and Acid value)

Product quality

View recall details →

Health Products Type II
2024-09-06

Immunig Nasal drops; Out of specification (Peroxide value)

Product quality

View recall details →

Health Products Type II
2024-08-09

Recall: Teva- Bupropion 300mg - lower strength tablet

Product quality

View recall details →

Health Products Type II
2024-08-07

Recall: JAMP Rabeprazole 10mg Over-sized delayed release tablets

Product quality

View recall details →

Health Products Type I
2024-08-05

Expanded recall: ratio-ECTOSONE (TEVA-ECTOSONE) 0.1% regular lotion and 0.05% mild lotion recalled due to an impurity that may pose health risks

Product quality - Labelling

View recall details →

Other
2024-08-03

Expanded recall: ratio-ECTOSONE (TEVA-ECTOSONE) 0.1% regular lotion and 0.05% mild lotion recalled due to an impurity that may pose health risks

Product quality

View recall details →

Health Products Type II
2024-06-27

Teva-Topilene 0.05% Ointment: Out of Specification

Product quality

View recall details →

Health Products
2024-06-26

Nomad Hand Sanitizer: Incorrect Expiry Date

Product quality

View recall details →

Health Products Type II
2024-06-25

JAMP-Doxazosin 4 mg: The uniformity of dosage unit may be out of specification in the affected lot.

Product quality

View recall details →

Health Products Type I
2024-06-14

Dianeal PD4 2.5% Dextrose and Physioneal 40 2.27% Glucose peritoneal dialysis solutions recalled due to risk of leakage at connection site

Product quality

View recall details →

Health Products Type I
2024-06-07

PMS-PIRFENIDONE 267 & 801 mg: Data integrity concerns with products bioequivalence data that could lead to incorrect dosing.

Product quality

View recall details →

Health Products Type I
2024-06-06

Mint-Betahistine 8, 16 & 24mg: Data integrity concerns with product's bioequivalence data that could lead to incorrect dosing.

Product quality

View recall details →

Health Products Type III
2024-06-03

Octaplasma solution: exposed to temperatures outside of the recommended storage conditions

Product quality

View recall details →

Health Products Type I
2024-06-03

Jamp Digoxin tablet: Over-sized tablet

Product quality

View recall details →

Health Products Type II
2024-05-27

Probiotic antibiotic support capsule: Out-of-specification (Bacterial content)

Product quality

View recall details →

Health Products Type II
2024-05-23

Tisseel Kit; Out-of-specification (Dissolution)

Product quality

View recall details →

Health Products Type I
2024-05-16

Sanis Health Duloxetine 60 mg Capsule; Exceeds acceptable interim intake limit for N-nitroso-duloxetine (NDLX)

Product quality

View recall details →

Other Health Products Hazards

COVID (279)Labelling (73)Contamination (61)Packaging (45)

Browse all recalls by hazard, allergen & year →